期刊
TRENDS IN BIOTECHNOLOGY
卷 29, 期 4, 页码 167-173出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2010.12.006
关键词
-
资金
- MRC [G0400848] Funding Source: UKRI
- Medical Research Council [G0400848, G1100127] Funding Source: Medline
- Medical Research Council [G0400848] Funding Source: researchfish
The development of new antibacterial agents to combat worsening antibiotic resistance is still a priority area in anti-infectives research, but in the post-genomic era it has been more difficult than expected to identify new lead compounds from high-throughput screening, and very challenging to obtain antibacterial activity for lead compounds. Bacterial cell-wall peptidoglycan biosynthesis is a well-established target for antibacterial chemotherapy, and recent developments enable the entire biosynthetic path way to be reconstituted for detailed biochemical study and high-throughput inhibitor screening. This review article discusses recent developments in the availability of peptidoglycan biosynthetic intermediates, the identification of lead compounds for both the earlier cytoplasmic steps and the later lipid-linked steps, and the application of new methods such as structure-based drug design, phage display and surface science.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据